3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
1059
Neoplasms
885
Prostatic Neoplasms
510
Lung Neoplasms
426
Colorectal Neoplasms
358
Motor Activity
226
Uterine Cervical Neoplasms
194
Head and Neck Neoplasms
194
Carcinoma, Non-Small-Cell Lung
182
Brain Neoplasms
174
Pancreatic Neoplasms
162
Ovarian Neoplasms
143
Colonic Neoplasms
140
Carcinoma, Hepatocellular
136
Anxiety Disorders
125
Rectal Neoplasms
119
Hematologic Neoplasms
115
Multiple Myeloma
109
Stomach Neoplasms
105
Neoplasm Metastasis
100
Precursor Cell Lymphoblastic Leukemia-Lymphoma
97
Melanoma
93
Depression
93
Pain
89
Urinary Bladder Neoplasms
88
Endometrial Neoplasms
87
Glioblastoma
86
Disease
85
Lymphoma
84
Sarcoma
78
Interventions
Blood Specimen Collection
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Vascular Diseases
×
1 year
×
Clear all
NCT06020651
2026-04-08
VICKI
Institut Mutualiste Montsouris
Phase NA
Completed
39 enrolled
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled